Angiotech, Boston Scientific Sue Conor Medsystems Over Drug-Coated Stents

Law360, New York (February 2, 2005, 12:00 AM EST) -- Canada’s Angiotech Pharmaceuticals Inc. and its corporate partner, Boston Scientific Corp., have filed a patent infringement lawsuit against Conor Medsystems Inc. in Dutch courts in an effort to stop the rival from commercializing its paclitaxel-coated stent.

The lawsuit comes a week after the European Patent Office maintained the validity of Angiotech's patent with various claims, including claims to stents coated with paclitaxel and a polymeric carrier.

In November, Boston Scientific, which distributes Angiotech's paclitaxel drug worldwide, agreed to increase its royalty payments to the company....
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.